Literature DB >> 19153326

Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.

Matteo Cescon1, Alessandro Cucchetti, Gian Luca Grazi, Alessandro Ferrero, Luca Viganò, Giorgio Ercolani, Matteo Zanello, Matteo Ravaioli, Lorenzo Capussotti, Antonio Daniele Pinna.   

Abstract

OBJECTIVE: To produce a model indicating the extent of hepatectomy for hepatocellular carcinoma on cirrhosis based on easily available preoperative data.
DESIGN: Retrospective study based on multicenter prospectively updated databases.
SETTING: Two tertiary referral centers specializing in hepatobiliary surgery. PATIENTS: A total of 466 patients undergoing hepatectomy for hepatocellular carcinoma on cirrhosis between 1995 and 2006. MAIN OUTCOME MEASURES: To create a decision tree for safe liver resection based on factors affecting irreversible postoperative liver failure (IPLF).
RESULTS: A total of 23 patients (4.9%) developed IPLF. The model for end-stage liver disease (MELD) score (categorized as <9, 9-10, and >10; P < .05 for all comparisons) and extent of hepatectomy were independent predictors of IPLF. In patients with a MELD score of less than 9, the IPLF rate was 0.4%. In patients with a MELD score of 9 or 10, the IPLF rate was 1.2% for resections of less than 1 segment, 5.1% for segmentectomies or bisegmentectomies, and 11.1% for major hepatectomies. In this category of MELD, serum sodium levels identified a low-risk group (sodium > or =140 mEq/L; to convert to millimoles per liter, multiply by 1.0) not experiencing IPLF and a high-risk group (sodium <140 mEq/L) in which resections of less than 1 segment led to an IPLF rate of 2.5% and resections of 1 segment or more led to an IPLF rate of more than 5% (P < .05). In patients with a MELD score of more than 10, the IPLF rate was more than 15% in all types of hepatectomies.
CONCLUSION: A simple algorithm based on the MELD score and serum sodium level can indicate the maximum tolerable extent of hepatectomy for hepatocellular carcinoma on cirrhosis.

Entities:  

Mesh:

Year:  2009        PMID: 19153326     DOI: 10.1001/archsurg.2008.522

Source DB:  PubMed          Journal:  Arch Surg        ISSN: 0004-0010


  15 in total

Review 1.  Management of hepatocellular carcinoma.

Authors:  P Fitzmorris; M Shoreibah; B S Anand; A K Singal
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-27       Impact factor: 4.553

Review 2.  Staging systems of hepatocellular carcinoma: a review of literature.

Authors:  Marcello Maida; Emanuele Orlando; Calogero Cammà; Giuseppe Cabibbo
Journal:  World J Gastroenterol       Date:  2014-04-21       Impact factor: 5.742

Review 3.  Comparative analysis of current guidelines for the treatment of hepatocellular carcinoma.

Authors:  Francesco Tovoli; Giulia Negrini; Luigi Bolondi
Journal:  Hepat Oncol       Date:  2016-03-23

Review 4.  Model for End-stage Liver Disease.

Authors:  Ashwani K Singal; Patrick S Kamath
Journal:  J Clin Exp Hepatol       Date:  2012-12-01

Review 5.  A worldwide survey of the current daily practice in liver surgery.

Authors:  Yoshihiro Mise; Yoshihiro Sakamoto; Takeaki Ishizawa; Junichi Kaneko; Taku Aoki; Kiyoshi Hasegawa; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Liver Cancer       Date:  2013-01       Impact factor: 11.740

Review 6.  Surgery in the patient with liver disease.

Authors:  Lawrence S Friedman
Journal:  Trans Am Clin Climatol Assoc       Date:  2010

Review 7.  Intermediate hepatocellular carcinoma: How to choose the best treatment modality?

Authors:  Giovan Giuseppe Di Costanzo; Raffaella Tortora
Journal:  World J Hepatol       Date:  2015-05-28

8.  Hepatocellular carcinoma treated by conventional transarterial chemoembolization in field-practice: serum sodium predicts survival.

Authors:  Marco Biolato; Luca Miele; Vittoria Vero; Simona Racco; Carmine Di Stasi; Roberto Iezzi; Andrea Zanché; Maurizio Pompili; Gian Ludovico Rapaccini; Giuseppe La Torre; Antonio Gasbarrini; Antonio Grieco
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

9.  Effects of low extracellular sodium on proliferation and invasive activity of cancer cells in vitro.

Authors:  Giada Marroncini; Benedetta Fibbi; Alice Errico; Cecilia Grappone; Mario Maggi; Alessandro Peri
Journal:  Endocrine       Date:  2019-11-29       Impact factor: 3.633

Review 10.  Current concepts in hepatic resection for hepatocellular carcinoma in cirrhotic patients.

Authors:  Alessandro Cucchetti; Matteo Cescon; Franco Trevisani; Antonio Daniele Pinna
Journal:  World J Gastroenterol       Date:  2012-11-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.